Diagnosis of synchronous primary lung adenocarcinomas based on epidermal growth factor (EGFR) gene status: A case report

Lung Cancer

Volumn 68, Issue 3, 2010, Pages 498-500

  Takuwa, Teruhisa ^a   Tanaka, Fumihiro ^a   Yoneda, Kazue ^a   Torii, Ikuko ^a   Hashimoto, Masaki ^a   Okumura, Yoshitomo ^a   Matsumoto, Seiji ^a   Kondo, Nobuyuki ^a   Hasegawa, Seiki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Adenocarcinoma; EGFR; Lung cancer; Multiple primary cancer; Pulmonary metastasis

Indexed keywords

ARGININE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORODEOXYGLUCOSE; GEFITINIB; K RAS PROTEIN; LEUCINE; EPIDERMAL GROWTH FACTOR; QUINAZOLINE DERIVATIVE;

ABSENCE OF SIDE EFFECTS; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER CONTROL; CANCER DIAGNOSIS; CANCER RECURRENCE; CASE REPORT; CLINICAL DECISION MAKING; CODON; COMPUTER ASSISTED TOMOGRAPHY; EXON; FEMALE; FOLLOW UP; GENE IDENTIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPANESE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG LOBECTOMY; LUNG METASTASIS; LUNG NODULE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDIASTINUM METASTASIS; MUTATIONAL ANALYSIS; PAPILLARY CARCINOMA; PATIENT REFERRAL; POINT MUTATION; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; THORACOTOMY; THORAX RADIOGRAPHY; TREATMENT RESPONSE; ADENOCARCINOMA; ANTAGONISTS AND INHIBITORS; CANCER STAGING; DIFFERENTIAL DIAGNOSIS; GENETICS; LUNG NEOPLASMS; LUNG RESECTION; METASTASIS; NEOPLASMS, MULTIPLE PRIMARY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PNEUMONECTOMY; QUINAZOLINES; RADIOGRAPHY, THORACIC;

EID: 77952545818     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.02.008     Document Type: Article

References (10)

1. Ferguson M.K., DeMeester T.R., DesLauriers J., Little A.G., Piraux M., Golomb H. Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg 1985, 89:378-385.
2. Mathisen D.J., Jensik R.J., Faber L.P., Kittle C.F. Survival following resection for second and third primary lung cancers. J Thorac Cardiovasc Surg 1984, 88:502-510.
3. Shimizu S., Yatabe Y., Koshikawa T., Haruki N., Hatooka S., Shinoda M., et al. High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis. Clin Cancer Res 2000, 6:3994-3999.
4. Martini N., Melamed M.R. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975, 70:606-612.
5. Sonobe M., Manabe T., Wada H., Tanaka F. Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma. Br J Cancer 2005, 93:355-363.
6. Tomizawa Y., Iijima H., Sunaga N., Sato K., Takise A., Otani Y., et al. Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer. Clin Cancer Res 2005, 11:6816-6822.
7. Ji H., Li D., Chen L., Shimamura T., Kobayashi S., McNamara K., et al. The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. Cancer Cell 2006, 9:485-495.
8. Stinchcombe T.E., Socinski M.A. Current treatments for advanced stage non-small cell lung cancer. Proc Am Thorac Soc 2009, 6:233-241.
9. Mok T.S., Wu Y.L., Thongprasert S., Yang C.H., Chu D.T., Saijo N., et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009, 361:947-957.
10. Rosell R., Moran T., Queralt C., Porta R., Cardenal F., Camps C., et al. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 2009, 361:958-967.